Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06261424Not ApplicableRecruiting

Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias

Role: collaborator

NCT05479656Not ApplicableCompleted

A Rehabilitation Program to Increase Balance and Mobility in Ataxia of Charlevoix-Saguenay

Role: collaborator

NCT04009408Not ApplicableUnknown

Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders

Role: collaborator

NCT01437345Completed

A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD

Role: collaborator

All 4 trials loaded